IGF1 and hepatocellular carcinoma: Additionally, low baseline serum IGF1 levels are reportedly associated with shorter time-to-progression (TTP) and poorer overall survival (OS) in patients with HCC, irrespective of the grade of hepatic dysfunction [15, 16].